IL1B and neurodegenerative disease: IL-1β can activate microglia and astrocytes, leading to the synthesis of proinflammatory and chemotactic mediators, and perpetuate a variety of CNS diseases including multiple sclerosis, neurodegenerative diseases, traumatic brain injury, and diabetic retinopathy (53).